Drugs / GCSF (Growth colony stimulating factor)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00001832 Background | Aug 1999 → May 2010 | melanoma, metastatic neoplasm | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GCSF (Growth colony stimulating factor) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001832 ↗ |
| Route | Subcutaneous | “GCSF will be administered subcutaneously at a dose of 5mcg/kg/day” NCT00001832 ↗ |